In recent trading, Clover Health Investments Corp (CLOV) stock price has shown some volatility, fluctuating 3.25% over the last five trades and 34.44% over the past 30 trades. This represents a ...

In terms of valuation, Vincerx Pharma Inc’s market capitalization stands at $3.62 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

Leerink Partnrs also issued estimates for Halozyme Therapeutics’ Q2 2025 earnings at $1.04 EPS, Q3 2025 earnings at $1.41 EPS and FY2029 earnings at $8.16 EPS. Get Halozyme Therapeutics alerts: ...

Leerink Partners analyst Andrew Berens maintained a Buy rating on Immunome (IMNM – Research Report) on January 13. The company’s shares closed yesterday at $9.38. Discover outperforming stocks ...

Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its price objective raised by Leerink Partners from $18.00 to $20.00 in a research report issued to clients and investors on Monday ...

Leerink notes that Eli Lilly (LLY) lowered its Q4 total revenue guidance by 5% but issued initial 2025 revenue guidance 2% above consensus. Q4 Mounjaro and Zepbound sales were approximately 18% ...

On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...

Op maandag zagen de aandelen van Progyny een verandering in hun marktvooruitzichten toen Leerink Partners het koersdoel van het bedrijf aanpaste. Analisten van Leerink Partners verhoogden het ...

On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...

Fintel reports that on January 6, 2025, Leerink Partners upgraded their outlook for Align Technology (WBAG:ALGN) from Market Perform to Outperform. There are 1,519 funds or institutions reporting ...